Paclitaxel-induced apoptosis in human gastric carcinoma cell lines

Cancer

Volumn 77, Issue 1, 1996, Pages 14-18

  Chang, Yuh Fang ^a   Li, Li Lydia ^a   Wu, Chew Wun ^a,b   Liu, Tsung Yun ^b   Lui, Wing Yiu ^a,b   P'eng, Fang Ku ^a,b   Chi, Chin Wen ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

flow cytometry; gastric carcinoma; paclitaxel; proliferating cell nuclear antigen

Indexed keywords

CYCLINE; PACLITAXEL;

APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL VIABILITY; DRUG CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STOMACH CARCINOMA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL SURVIVAL; DIMETHYL SULFOXIDE; FLOW CYTOMETRY; HUMANS; PACLITAXEL; PROLIFERATING CELL NUCLEAR ANTIGEN; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030045450     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960101)77:1<14::AID-CNCR4>3.0.CO;2-N     Document Type: Article

References (25)

1. Health and vital statistics. Department of Health, the Executive Yuan, Republic of China, September 1994.
2. Kodama Y, Sugimachi K, Soejima K, Matsusaka T, Inokuchi K. Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg 1981;5:241-8.
3. Higgins GA, Amadeo JH, Smith DE, Humphrey EW, Keehn RJ. Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A Veterans Administration Surgical Oncology Group Report. Cancer 1983;52:1105-12.
4. Wisbeck WM, Becher EM, Russell AH. Adenocarcinoma of the stomach: autopsy observations with therapeutic implications for the radiation oncologist. Radiother Oncol 1986;7:13-8.
5. Wani MC, Taylor HL, Wall ME, Goggon P, Mcphail AT. Plant antitumor agents. VI. The isolation and structure of Taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 1971;93:2325-7.
6. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by Taxol. Nature 1979;277:665-7.
7. Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 1980;77:1561-5.
8. cdc2 coincident with Taxol-induced apoptosis. Cell Growth Differ 1994;5:1041-50.
9. Paull KD, Lin CM, Malspeis L, Hamel E. Identification of novel antimitotic agents acting at the tubulin level by computer assisted evaluation of differential cytotoxicity data. Cancer Res 1992;52:3892-900.
10. Bissery MC, Guenard D, Voegelein FG, Lavelle F. Experimental antitumor activity of taxotere (RP56976, NSC628503), a Taxol analogue. Cancer Res 1991;51:4845-52.
11. Holmes FA, Frye D, Theriault RL, Waters RS, Forman AD, Newton LK, et al. Phase II study of Taxol in patients with metastatic breast cancer. Proc Am Soc Clin Oncol 1991;10:60.
12. Legha SS, Ring SP, Raber N, Papadopoulos N, Raber M, Benjamin RS. Phase II study of Taxol in metastatic melanoma. Cancer 1990;65:2478-81.
13. Einzig AI, Wernik P, Sasloff I. Phase II studies of Taxol in patients with advanced ovarian cancer. Proc Am Assoc Cancer Res 1990;31:1114.
14. Tishler RB, Geard CR, Hall EJ, Schiff PB. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 1992;52:3495-7.
15. Stearns ME, Wang M. Taxol blocks processes essential for prostate tumor cell (PC-3ML) invasion and metastasis. Cancer Res 1992;52:3776-81.
16. Speicher LA, Barone L, Tew KD. Combined antimicrotubule activity of estramustine and Taxol in human prostatic carcinoma cell lines. Cancer Res 1992;52:4433-40.
17. Sekiguchi M, Sakakibara K, Fuji G. Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 1978;48:61-8.
18. Jin L, Meng CL, Han SH, Ding MJ, Chang TM, Chen VTK, et al. A study on production of monoclonal antibodies using SC-M1 cells as immunogen. J Med Sci 1987;8:17-25.
19. Landberg G, Roos G. Antibodies to proliferating cell nuclear antigen (PCNA) as S-phase probes in flow cytometric cell cycle analysis. Cancer Res 1991;51:4570-5.
20. Shivji MK, Kenny MK, Wood RD. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 1992;69:367-74.
21. Liebmann JE, Cook JA, Lipschultz C, Teague D, Fisher J, Mitchell JB. Cytotoxic studies of paclitaxel (Taxol) in human tumor cell lines. Br J Cancer 1993;68:1104-9.
22. Vanhoeger U, Stahl M, Wilke H, Schleucher N, Harstrick A, Schmiedel C, et al. High activity of Taxol in human gastric cancer lines (Meeting abstract) Rev Oncol 1993;3:9-10.
23. Tomei LD, Shapiro JP, Cope FO. Apoptosis in C3H/10T1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc Natl Acad Sci USA 1993;90:853-7.
24. Liebmann JE, Hahn SM, Cook JA, Lipschultz C, Mitchell JB, Kaufman DC. Glutathione depletion by L-buthionine sulfoximine antagonizes Taxol cytotoxicity. Cancer Res 1993;53: 2066-70.
25. Wojciech G, Barbara A, Zbigniew D. Different rates of degradation of the proliferation-associated nuclear and nucleolar antigens during apoptosis of HL-60 cells induced by DNA topoisomerase inhibitors. Int J Oncol 1993;3:627-34.